Prediction of immune related adverse events by genetic analysis
Not Applicable
Recruiting
- Conditions
- malignant melanoma, lung cancer, renal cancer, Hodgkin lymphoma
- Registration Number
- JPRN-UMIN000026047
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under clinical trial
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immune related adverse event
- Secondary Outcome Measures
Name Time Method efficacy of the treatment